跳至主要内容
临床试验/2024-515986-33-00
2024-515986-33-00招募中2 期

Dose escalating study to evaluate pharmacokinetics, efficacy and safety of apotransferrin in atransferrinemia patients

Prothya Biosolutions Netherlands B.V.3 个研究点 分布在 3 个国家目标入组 5 人开始时间: 2024年8月2日最近更新:
相关药物

试验速览

阶段
2 期
状态
招募中
入组人数
5
试验地点
3
主要终点
Decrease of serum ferritin (to normal range)

研究概览

简要总结

To investigate the pharmacokinetics, efficacy and safety of apotransferrin replacement therapy

研究设计

研究类型
Interventional
分配方式
Non-randomized
主要目的
Long-term Follow-up
盲法
None

入排标准

年龄范围
0 years 至 64 years(18-64 Years, 0-17 Years)
接受健康志愿者

入选标准

  • Established diagnosis of atransferrinemia, defined as serum levels of transferrin below 40 mg/dL
  • Signed informed consent

排除标准

  • Known with allergic reactions against human plasma or plasma products
  • Having detectable anti-IgA antibodies
  • Fertile women unless they take valid contraceptive measures (ITA only)

结局指标

主要结局

Decrease of serum ferritin (to normal range)

Decrease of serum ferritin (to normal range)

Increase of hemoglobin (to normal range)

Increase of hemoglobin (to normal range)

Pharmacokinetics of transferrin

Pharmacokinetics of transferrin

次要结局

  • Decrease of iron overload (liver, heart)
  • Transferrin levels, transferrin saturation, and serum iron in relation to efficacy
  • Undetectable NTBI/LPI levels
  • Increase of hematocrit (to normal range)
  • Increase of erythrocytes (to normal range)

研究者

申办方类型
Pharmaceutical company
责任方
Principal Investigator
主要研究者

Ilona Kleine Budde

Scientific

Prothya Biosolutions Netherlands B.V.

研究点 (3)

Loading locations...

相似试验

进行中(未招募)
1 期
Clinical trial to investigate the treatment with apotransferrin of patients with atransferrinemiaAtransferrinemiaMedDRA version: 20.0Level: LLTClassification code 10055212Term: Hypochromic microcytic anemiaSystem Organ Class: 100000004851MedDRA version: 20.0Level: LLTClassification code 10002272Term: AnemiaSystem Organ Class: 100000004851MedDRA version: 21.0Level: PTClassification code 10065973Term: Iron overloadSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 21.0Level: PTClassification code 10005620Term: Blood iron increasedSystem Organ Class: 10022891 - InvestigationsMedDRA version: 20.0Level: PTClassification code 10044356Term: Transferrin decreasedSystem Organ Class: 10022891 - Investigations
EUCTR2009-017409-13-DEProthya Biosolutions Netherlands B.V.6
招募中
1 期
Clinical trial to investigate the treatment with apotransferrin of patients with atransferrinemiaCongenital atransferrinaemia/ hypotransferrinaemiaMedDRA version: 23.1Level: PTClassification code: 10084860Term: Hypotransferrinaemia Class: 100000004851MedDRA version: 23.0Level: LLTClassification code: 10083978Term: Congenital atransferrinaemia Class: 10010331MedDRA version: 20.0Level: PTClassification code: 10044356Term: Transferrin decreased Class: 100000004848MedDRA version: 21.0Level: PTClassification code: 10065973Term: Iron overload Class: 100000004861MedDRA version: 20.0Level: LLTClassification code: 10055212Term: Hypochromic microcytic anemia Class: 10005329MedDRA version: 21.0Level: PTClassification code: 10005620Term: Blood iron increased Class: 100000004848
CTIS2024-515986-33-00Prothya Biosolutions Netherlands B.V.4
进行中(未招募)
不适用
Dose escalating study to evaluate pharmacokinetics, efficacy and safety of apotransferrin in atransferrinemia patients. Estudio de escalada de dosis para evaluar la farmacocinÊtica, la eficacia y la seguridad de apotransferrina, en pacientes con atransferrinemia. - Apotransferrin replacement in atransferrinemiaAtransferrinemiaMedDRA version: 12.1Level: LLTClassification code 10044357Term: Transferrin increasedMedDRA version: 12.1Level: LLTClassification code 10005620Term: Blood iron increasedMedDRA version: 12.1Level: LLTClassification code 10002272Term: Anemia
EUCTR2009-017409-13-ESSanquin Plasma Products
招募中
不适用
Dose escalation trial to evaluate the safety and the efficacy on new bone formation of a single local treatment with lithium carbonate to teeth extraction sockets for dental implant in Japanese participants
JPRN-UMIN000008795Kyushu University Hospital12
进行中(未招募)
不适用
A study in Rheumatoid Arthritis patients to look at two formulations of adalimumab for pharmacokinetics and safety.MedDRA version: 14.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersRheumatoid Arthritis
EUCTR2012-000535-36-CZAbbott GmbH & Co. KG100